PRPO MEXC RealStocks
Own real PRPO shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-14 12:39:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Precipio, Inc. (PRPO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $22.31, with a market capitalization of $41.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.79 to $33.63. This page covers its latest market performance, valuation, price trends and company information.
$41.69M | |
$23.24 | |
$23.24 | |
$21.42 | |
$23.25 | |
13.52K | |
91.69K | |
-- | |
$33.63 | |
$17.79 | |
-- | |
-- |
Precipio, Inc. (PRPO) last closed at $22.31 as of 2026-11-14 00:31:00, down 2.84% ($0.66) from the previous close of $23.25.
During the latest regular trading session, PRPO traded between $21.42 and $23.24, with a volume of 13.52K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Precipio, Inc. (PRPO) moved from $18.59 to $22.31, representing a gain of 19.99% ($3.72).
The stock traded between $18.48 and $25.34 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 24.01 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 28.5%
PRPO is currently trading at $22.31, placing it 28.5% of the way from its 52-week low of $17.79 to its 52-week high of $33.63. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 71 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Precipio, Inc. (PRPO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PRPO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PRPO shares and USD.
PRPO Shares to USD
1.00 PRPO shares = 22.306 USD
Calculations are estimates based on the latest available price and are for reference only.